|
2015 Conference Publication Developing safe haematological monitoring guidelines for patients with myeloma on bortezomib based regimensWoodrow, C. and Mollee, P. (2015). Developing safe haematological monitoring guidelines for patients with myeloma on bortezomib based regimens. 15th International Myeloma Workshop, Rome, Italy, 23-26 September 2015. New York, NY United States: Elsevier. doi: 10.1016/j.clml.2015.08.097 |
|
2015 Conference Publication Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot studyMollee, P., Law, W. Phillip, Wang, W. Y. S, Moore, P. T. and Ng, A. C. T (2015). Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot study. International Myeloma Workshop, Rome, Italy, 23-26 September 2015. New York, NY United States: Elsevier. doi: 10.1016/j.clml.2015.07.416 |
|
2015 Conference Publication Emergence of Fc gamma RIIb-dominance contributes to resistance to therapeutic antibodies in chronic lymphocytic leukemia patientsBurgess, Melinda, Gill, Devinder, Mapp, Sally, Ellis, Jonathan, Cheung, Catherine, Chambers, Lynne, Mattarollo, Stephen, Mollee, Peter and Saunders, Nicholas (2015). Emergence of Fc gamma RIIb-dominance contributes to resistance to therapeutic antibodies in chronic lymphocytic leukemia patients. XVI International Workshop on Chronic Lymphocytic Leukaemia 2015, Sydney, NSW, Australia, 6–9 September 2015. Abingdon, Oxfordshire, United Kingdom: Taylor & Francis. |
|
2015 Conference Publication Diagnosis of Amyloidosis Subtype By Laser-Capture Microdissection (LCM) and Tandem Mass Spectrometry (MS/MS) Proteomic AnalysisMollee, Peter, Renaut, Patricia, Boros, Samuel, Loo, Dorothy and Hill, Michelle (2015). Diagnosis of Amyloidosis Subtype By Laser-Capture Microdissection (LCM) and Tandem Mass Spectrometry (MS/MS) Proteomic Analysis. 57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL United States, 5-8 December 2015. Washington, DC United States: American Society of Hematology. |
|
2014 Conference Publication Recommendations for Serum Free Light Chains (Sflc) Measurement in Routine LaboratoriesTate, Jill, Jovanovich, Sue, Mollee, Peter, Chiu, Weldon, Wienholt, Louise, Gillis, David, Reibelt, Lindsay and Youdell, Odette (2014). Recommendations for Serum Free Light Chains (Sflc) Measurement in Routine Laboratories. Unknown, Unknown, Unknown. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. |
|
2014 Conference Publication New diagnostic strategies for assessment of amyloidosis and myelomaMollee, Peter (2014). New diagnostic strategies for assessment of amyloidosis and myeloma. 48th Annual Scientific Meeting of the Australasian Division of the IAP, Brisbane, QLD Australia, 31 May – 2 June 2024. Oxford, United Kingdom: Elsevier. doi: 10.1097/01.pat.0000443473.89668.b2 |
|
2013 Conference Publication Diagnosis Of Amyloidosis Subtype By Laser-Capture Microdissection (LCM) and Tandem Mass Spectrometry (MS) Proteomic AnalysisMollee, Peter, Renaut, Patricia, Boros, Samuel, Loo, Dorothy and Hill, Michelle (2013). Diagnosis Of Amyloidosis Subtype By Laser-Capture Microdissection (LCM) and Tandem Mass Spectrometry (MS) Proteomic Analysis. 55th Annual Meeting of the American-Society-of-Hematology, New Orleans La, Dec 07-10, 2013. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2013 Conference Publication Rapid Molecular Diagnosis Of JAK2V617F Negative MPN By Targeted Deep Sequencing Using The Ion Torrent PGMKlose, Nathan, Tallack, Michael R, Magor, Graham, Mollee, Peter and Perkins, Andrew C (2013). Rapid Molecular Diagnosis Of JAK2V617F Negative MPN By Targeted Deep Sequencing Using The Ion Torrent PGM. 55th ASH Annual Meeting, New Orleans, LA, 7-10 December 2013. American Society of Hematology. doi: 10.1182/blood.v122.21.4093.4093 |
|
2013 Conference Publication Serum levels Of CD178 (Soluble FasL) predict treatment response and survival in chronic lymphocytic leukaemia (CLL)Mollee, Peter, Burgess, Melinda, McMillan, Nigel, Saunders, Nicholas, Cheung, Catherine, Hallek, Michael and Gill, Devinder S (2013). Serum levels Of CD178 (Soluble FasL) predict treatment response and survival in chronic lymphocytic leukaemia (CLL). 55th ASH Annual Meeting, New Orleans, LA, 7-10 December 2013. American Society of Hematology. doi: 10.1182/blood.v122.21.2866.2866 |
|
2013 Conference Publication Diagnosis of amyloidosis subtype by laser-capture microdissection (LCM) and tandem mass spectrometry (MS) proteomic analysisMollee, Peter, Renaut, Patricia, Boros, Samuel, Loo, Dorothy and Hill, Michelle (2013). Diagnosis of amyloidosis subtype by laser-capture microdissection (LCM) and tandem mass spectrometry (MS) proteomic analysis. 55th ASH Annual Meeting, New Orleans, LA United States, 7-10 December 2013. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.v122.21.5295.5295 |
|
2013 Conference Publication Immunosuppression (IST) Can Be Safely Ceased During Chemotherapy For Post-Transplant Lymphoproliferative Disorders (PTLD) In Renal Transplant PatientsTaylor, Emma, Jones, Mark, Hourigan, Matthew J., Johnson, David W., Gill, Devinder S., Isbel, Nicole, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher K., Campbell, Scott B. and Mollee, Peter (2013). Immunosuppression (IST) Can Be Safely Ceased During Chemotherapy For Post-Transplant Lymphoproliferative Disorders (PTLD) In Renal Transplant Patients. 55th Annual Meeting of the American Society of Hematology, New Orleans, LA United States, 7-10 December 2013. Washington, DC United States: American Society of Hematology. |
|
2013 Conference Publication Serum Levels Of CD178 (Soluble FasL) Predict Treatment Response and Survival In Chronic Lymphocytic Leukaemia (CLL)Mollee, Peter, Burgess, Melinda, McMillan, Nigel, Saunders, Nicholas, Cheung, Catherine, Hallek, Michael and Gill, Devinder S. (2013). Serum Levels Of CD178 (Soluble FasL) Predict Treatment Response and Survival In Chronic Lymphocytic Leukaemia (CLL). 55th Annual Meeting of the American-Society-of-Hematology, New Orleans La, Dec 07-10, 2013. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2012 Conference Publication Clinical comparison of the freelite and n-latex serum free light chain (FLC) assays in the diagnosis and monitoring of AL amyloidosisMapp, Sally, Tate, Jill, Pretorius, Carel and Mollee, Peter (2012). Clinical comparison of the freelite and n-latex serum free light chain (FLC) assays in the diagnosis and monitoring of AL amyloidosis. 54th ASH Annual Meeting, Atlanta, GA, 8-11 December 2012. American Society of Hematology. doi: 10.1182/blood.v120.21.4991.4991 |
|
2012 Conference Publication Outcomes and prognostic factors for patients with acute myeloid leukemia admitted to the intensive care unitJackson, Kathryn A., Mollee, Peter, Morris, Kirk, Jackson, Dwane L., Kruger, Peter, Klein, Kerenaftali and Kennedy, Glen A. (2012). Outcomes and prognostic factors for patients with acute myeloid leukemia admitted to the intensive care unit. 54th ASH Annual Meeting, Atlanta, GA United States, 8-11 December 2012. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.v120.21.3613.3613 |
|
2012 Conference Publication Intensive chemotherapy for acute myeloid leukemia in elderly patientsJackson, Kathryn A, Kennedy, Glen A, Mollee, Peter and Morris, Kirk (2012). Intensive chemotherapy for acute myeloid leukemia in elderly patients. 54th ASH Annual Meeting, Atlanta, GA, 8-11 December 2012. American Society of Hematology. doi: 10.1182/blood.v120.21.4341.4341 |
|
2012 Conference Publication Outcomes and prognostic factors for patients with Acute Myeloid Leukemia admitted to the intensive care unitJackson, Kathryn A., Mollee, Peter, Morris, Kirk, Jackson, Dwane L., Kruger, Peter, Klein, Kerenaftali and Kennedy, Glen A. (2012). Outcomes and prognostic factors for patients with Acute Myeloid Leukemia admitted to the intensive care unit. 54th Annual Meeting and Exposition of the American Society of Hematology (ASH), Atlanta, GA, United States, 8-11 December 2012. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood.V120.21.3613.3613 |
|
2012 Conference Publication Intensive Chemotherapy for Acute Myeloid Leukemia in Elderly PatientsJackson, Kathryn A., Kennedy, Glen A., Mollee, Peter and Morris, Kirk (2012). Intensive Chemotherapy for Acute Myeloid Leukemia in Elderly Patients. 54th Annual Meeting and Exposition of the American Society of Hematology (ASH), Atlanta, GA, United States, 8-11 December 2012. Washington, DC, United States: American Society of Hematology. |
|
2011 Conference Publication A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosisMollee, Peter, Tiley, Campbell, Cunningham, Ilona, Moore, John, Prince, Miles, Cannell, Paul, Gibbons, Steve, Tate, Jill, Paul, Sanjoy and Gill, Devinder S (2011). A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis. 53rd ASH Annual Meeting, San Diego, 10-13 December 2011. American Society of Hematology. doi: 10.1182/blood.v118.21.3973.3973 |
|
2011 Conference Publication Tissue microarray in DLBCL patients receiving R-CHOP chemo-immunotherapy shows survival benefit for coexpression of LMO2/BCL6Keane, Colm, Shen, Linda, Han, Erica, Nourse, Jamie P, Lea, Rod, Mollee, Peter, Gill, Devinder S and Gandhi, Maher K (2011). Tissue microarray in DLBCL patients receiving R-CHOP chemo-immunotherapy shows survival benefit for coexpression of LMO2/BCL6. 53rd ASH Annual Meeting, San Diego, 10-13 December 2011. American Society of Hematology. doi: 10.1182/blood.v118.21.1585.1585 |
|
2011 Conference Publication ZAP-70 expression measured by quantitative PCR (QPCR) as a prognostic marker in chronic lymphocytic leukaemia (CLL)Mollee, Peter, Banh, Raymond H., Cheung, Catherine, Saal, Russell, Chambers, Lynne, Pelly, Tennille and Gill, Devinder S (2011). ZAP-70 expression measured by quantitative PCR (QPCR) as a prognostic marker in chronic lymphocytic leukaemia (CLL). 53rd ASH Annual Meeting, San Diego, 10-13 December 2011. American Society of Hematology. doi: 10.1182/blood.v118.21.4602.4602 |
